Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank71
3Y CAGR-13.5%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-13.5%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.01+73.0%
20240.00-53.3%
20230.01-19.8%
20220.01-
20210.00-
20200.00-
20190.00-
20180.00-